This accredited meeting delivers practice-changing updates in breast, genitourinary, hematologic, gastrointestinal, and lung cancers with expert faculty, interactive panels, molecular tumor boards, and networking opportunities.
Highlights include CAR-T preparation, MRD in myeloma/AML, HER2 management, AI in oncology, and multidisciplinary panel Q&As. 
Registration is free for all healthcare providers. Click here to learn more.